SG

Sormistha Ghosh

Director DIN 07669095
DIN 07669095 First appointment Feb 2017
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Feb 2017
Shareholding value β€’β€’β€’β€’ Premium profile

About Sormistha Ghosh

Data last updated:

Sormistha Ghosh was a Director at Arrow Remedies Private Limited (from 2017) and Director at Fagris Medica Private Limieted (from 2019).

DIN 07669095
First Appointment 07 Feb 2017
Oldest Company Age 18 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Arrow Remedies Private Limited U33111MH2015FTC268380
Director07 Feb 20172015₹5,352 (FY 2020)Amalgamated
Fagris Medica Private Limieted U24230MH2008PTC271062
Director25 Oct 20192008₹45,181 (FY 2020)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Arrow Remedies Private Limited
Fagris Medica Private Limieted
Premium access

Shareholding and investment profile for Sormistha Ghosh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sormistha Ghosh

Sormistha Ghosh was first appointed on 07 Feb 2017 as Director at Arrow Remedies Private Limited. The most recent appointment on record is 25 Oct 2019 at Fagris Medica Private Limieted.

Sormistha Ghosh held 2 earlier board appointments: Arrow Remedies Private Limited (Director, from 07 Feb 2017); Fagris Medica Private Limieted (Director, from 25 Oct 2019).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available